Health Condition 1: K135- Oral submucous fibrosis
Conditions
Interventions
Intervention1: Triamcinolone injection: intralesional injection of Triamcinolone acetonide 40mg/ml
1 ml per session, once weekly for 6 weeks in oral mucosa intralesional
with standard physiotherapy
Sponsors
Hitkarini Dental College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients clinically diagnosed with Oral Submucous Fibrosis Classified under GROUP I GROUP III according to Ranganathan K et al (2001) Patients with reduced mouth opening and burning sensation in mouth.
Exclusion criteria
Exclusion criteria: Pregnant or lactating women . Patients who have any drug allergy. Patients showing signs of inflammatory reaction after injection. Patients with bleeding disorders. Medically compromised patients. Patients with clinical signs and symptoms or proven report of malignancy in oral cavity. Patients with Temporomandibular joint disorders or trauma to
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in interincisal mouth opening in millimetersTimepoint: baseline ( pre treatment), at the end of 6 months and at 3 months follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in burning sensation (measured by visual analog scale)Timepoint: baseline ( pre treatment), at the end of 6 months and at 3 months follow up;cheek flexibilityTimepoint: baseline ( pre treatment), at the end of 6 months and at 3 months follow up;change in color of tissue ( clinical)Timepoint: baseline ( pre treatment), at the end of 6 months and at 3 months follow up | — |
Countries
India
Contacts
Public ContactVipul Ughade
Hitkarini Dental College and Hospital
Outcome results
None listed